World Investment Advisors purchased a new stake in shares of Columbia Research Enhanced Value ETF (NYSEARCA:REVS – Free Report) during the 4th quarter, according to its most recent Form 13F filing with the SEC. The institutional investor purchased 41,326 shares of the company’s stock, valued at approximately $1,169,000. World Investment Advisors owned 0.63% of Columbia Research Enhanced Value ETF at the end of the most recent reporting period.
A number of other institutional investors and hedge funds have also recently modified their holdings of REVS. NewEdge Advisors LLC increased its position in Columbia Research Enhanced Value ETF by 13.4% during the second quarter. NewEdge Advisors LLC now owns 122,687 shares of the company’s stock valued at $3,224,000 after acquiring an additional 14,498 shares during the last quarter. Raymond James Financial Inc. boosted its position in Columbia Research Enhanced Value ETF by 396.4% in the second quarter. Raymond James Financial Inc. now owns 200,098 shares of the company’s stock worth $5,259,000 after purchasing an additional 159,786 shares during the last quarter. Private Advisor Group LLC purchased a new position in Columbia Research Enhanced Value ETF in the third quarter worth about $448,000. Wealth Enhancement Advisory Services LLC boosted its position in Columbia Research Enhanced Value ETF by 4.7% in the fourth quarter. Wealth Enhancement Advisory Services LLC now owns 105,326 shares of the company’s stock worth $3,052,000 after purchasing an additional 4,757 shares during the last quarter. Finally, U.S. Capital Wealth Advisors LLC bought a new stake in shares of Columbia Research Enhanced Value ETF during the 4th quarter valued at about $3,446,000.
Columbia Research Enhanced Value ETF Price Performance
Columbia Research Enhanced Value ETF stock opened at $31.63 on Monday. Columbia Research Enhanced Value ETF has a 52-week low of $25.55 and a 52-week high of $32.21. The company has a market cap of $291.00 million, a P/E ratio of 16.41 and a beta of 0.80. The business has a 50-day simple moving average of $30.92 and a two-hundred day simple moving average of $29.68.
About Columbia Research Enhanced Value ETF
The Columbia Research Enhanced Value ETF (REVS) is an exchange-traded fund that mostly invests in large cap equity. The fund tracks an index of US stocks pulled from the Russell 1000 Value Index. REVS index uses multifactor selection and market cap weighting. REVS was launched on Sep 25, 2019 and is managed by Columbia.
Recommended Stories
- Five stocks we like better than Columbia Research Enhanced Value ETF
- 3 Inflation-Fighting Stocks Built for Higher Oil Prices
- 3 Biotech Firms With Major Potential Catalysts in the Coming Months
- Applied Materials Stock Looks Pricey—Can AI Demand Justify the Rally?
- 3 Small-Cap Stocks Getting a Russell 2000 Rebalance Boost
Receive News & Ratings for Columbia Research Enhanced Value ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Columbia Research Enhanced Value ETF and related companies with MarketBeat.com's FREE daily email newsletter.
